NSEAnalysts/Institutional Investor Meet/Con. Call Updates6d ago · 6 Aug 2026, 06:31 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Zota Health Care LImited · ZOTA
✦ AI SummaryResults
Zota Health Care Limited has informed the Exchange about Intimation of Schedule of Earnings Conference Call on Q1FY27 Results.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zota Health Care Limited has informed the Exchange about Intimation of Schedule of Earnings Conference Call on Q1FY27 Results
Attachments (1)
📄pdf
Download →
ZOTA_06082026183113_IntEC06082026.pdf
View document text
August 06, 2026
The Manager
Listing Department,
The National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400051
Dear Sir/Madam,
Trading Symbol: ZOTA
Sub.: Intimation of Schedule of Earnings Conference Call on Q1FY27 Results
Ref.: Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
With reference to the captioned subject; we, Zota Health Care Limited (the “Company”), would like to
inform you that the Company will host an Earnings Call on Q1FY27 Results on Friday, August 14, 2026 at
11:30 hrs. (IST).
The conference call invitation is enclosed herewith.
This is for your information and record.
Thanking you,
Yours faithfully,
For Zota Health Care Limited
Ashvin Variya
(Group Company Secretary & Compliance Officer)
Place: Surat
Encl.: a/a
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email: info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
ress Release – Q2FY22
Earnings Call Invite
Q1FY27
Zota Health Care Limited Q1FY27 Earnings Call to be held on Friday, August 14, 2026, at
11:30 hrs. (IST)
Surat, August 06, 2026: Zota Health Care Limited, one of the leading pharmaceutical Company with an aim to provide
affordable, high-quality, generic medicines predominantly for chronic conditions, in addition to proprietary medicinal,
OTC, ayurvedic, cosmetic, and nutraceutical products, will announce financial results for the first quarter ended June
30, 2026 on August 13, 2026. Following the announcement, the management of the Company will host an Earnings
Call on Friday, August 14, 2026, at 11:30 hrs. (IST).
The Details of Q1FY27 Earnings Call are:
Date: Friday, August 14, 2026
Time: 11:30 hrs. IST
Duration: 60 minutes
Dial-in Details:
Participants are encouraged to dial in 10 minutes prior to the call start time to avoid last-minute hold times. If you
reach an operator during the dial-in process, please inform them that you would like to join the “Zota Health Care
Limited Q1FY27 Earnings Conference Call’.
Universal Dail in numbers +91 22 6280 1107 / +91 22 7115 8008
Pre-Registration Facility • Step 1: Pre-register here. You will receive an email confirmation with
the call details on the registered email address.
• Step 2: Dial into the call on the Conference Call date, you will be
directly connected to the call.
Management Representation from Zota Health Care Limited
Mr. Himanshu Zota - Founder and Whole-time Director
Mr. Moxesh Zota - Managing Director
Dr. Sujit Paul - Group Chief Executive Officer
About Zota Health Care Limited:
Zota Health Care Ltd. (Zota), listed on the NSE, has been a key player in the Indian healthcare industry since 2000. Headquartered
in Surat, Zota's team of over 620 professionals drives its growth and strong market presence. The Company specializes in the
development, manufacturing, and marketing of high-quality pharmaceutical, ayurvedic, nutraceutical, and over-the-counter
products.
ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q1FY2027 EARNINGS CALL INVITE | PAGE 1 OF 2
ress Release – Q2FY22
Earnings Call Invite
Q1FY27
Zota operates through three main divisions: marketing, export, and the retail pharmacy chain. In 2017, Zota launched Davaindia,
a generic pharmacy chain offering over 2,000 SKUs of quality medicines. Davaindia's strategic business model ensures efficient
management of the entire product life cycle through backward and forward integration.
Zota is renowned for its innovative Research and Development team, consistently investing in pioneering healthcare solutions,
reinforcing its reputation in the industry. For more information, visit: www.zotahealthcare.com.
For details please contact:
Ashvin Variya Siddesh Chawan Ajit Mishra
Group Company Secretary & Compliance Officer Ernst & Young LLP, Ernst & Young LLP,
Zota Health Care Ltd Investor Relations Investor Relations
E: cszota@zotahealthcare.com E: Siddesh.Chawan@in.ey.com E: Ajit.J.Mishra@in.ey.com
Disclaimer: Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain
risks and uncertainties like government actions, local, political, or economic developments, technological risks, and many other factors that could cause actual
results to differ materially from those contemplated by the relevant forward-looking statements. Zota Health Care Ltd. will not be in any way responsible for any
action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or
circumstances.
ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q1FY2027 EARNINGS CALL INVITE | PAGE 2 OF 2